Internal Medicine, Hematology & Oncology · Shreveport, LA
NPI
1124174644
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2600 Kings Hwy, Suite 340
Shreveport, LA, 71103
Phone (318) 212-8620
Groups this clinician bills Medicare through
Medicare paid, 2024
$245K
3,219 services
Medicare patients, 2024
725
Average age 74
Drug cost, 2024
$5.4M
2,631 prescriptions
Company payments, 2025
$667
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anil Veluvolu was code 99214 (office e&m - established), 2,555 times for 634 patients. In total Anil Veluvolu billed 3,219 services in 9 codes, and Medicare paid $245K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-12-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 2,555 | 634 | $69.45 | $177K |
| 99215 Office E&M - Established | Facility | 231 | 147 | $104.13 | $24K |
| 99233 Hospital E&M - Subsequent | Facility | 153 | 62 | $91.04 | $14K |
| 99205 Office E&M - New | Facility | 121 | 121 | $134.24 | $16K |
| 99214 Office E&M - Established | Office | 78 | 71 | $56.70 | $4,423 |
| 99223 Hospital E&M - Initial | Facility | 47 | 44 | $132.68 | $6,236 |
| 99205 Office E&M - New | Office | 11 | 11 | $134.31 | $1,477 |
By year: 2022 $340K for 3,732 services; 2023 $255K for 3,426 services; 2024 $245K for 3,219 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anil Veluvolu prescribed most often to Medicare patients was Letrozole, with 190 prescriptions and refills. In total Anil Veluvolu wrote 2,631 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 190 | 258 | 31 | $2,214 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 163 | 163 | 55 | $3,960 |
| Prochlorperazine Maleate Generic | 141 | 143 | 86 | $4,858 |
| Ondansetron Odt Ondansetron | 118 | 118 | 85 | $3,822 |
| Xarelto Rivaroxaban | 112 | 153 | 20 | $83K |
| Eliquis Apixaban | 111 | 121 | 14 | $70K |
| Prednisone Generic | 97 | 97 | 26 | $382 |
| Revlimid Lenalidomide | 89 | 89 | 11 | $1.7M |
| Hydroxyurea Generic | 75 | 106 | 14 | $885 |
| Levothyroxine Sodium Generic | 74 | 102 | 16 | $592 |
| Oxycodone Hcl Generic | 73 | 73 | 27 | $2,604 |
| Anastrozole Generic | 69 | 107 | 13 | $635 |
| Promethazine Hcl Generic | 65 | 65 | 45 | $504 |
| Levofloxacin Generic | 63 | 71 | 47 | $285 |
| Imatinib Mesylate Generic | 63 | 63 | Under 11 | $191K |
Brand drugs: 575 claims; generic drugs: 2,056 claims; opioid claims: 294.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anil Veluvolu $667 ($667 in general payments such as food, travel and fees) from 15 companies. The largest payer was Tempus AI, Inc with $140.
| Company | Payments | Amount |
|---|---|---|
| Tempus AI, Inc TEM | 6 | $140 |
| Abbvie Inc. ABBV | 5 | $133 |
| Seagen Inc. PFE | 1 | $82.65 |
| Astellas Pharma US Inc 4503.T | 3 | $68.59 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $58.08 |
| Daiichi Sankyo Inc. 4568.T | 2 | $43.63 |
| GlaxoSmithKline, LLC. GSK | 1 | $26.28 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $23.72 |
| Merck Sharp & Dohme LLC MRK | 1 | $22.2 |
| TerSera Therapeutics LLC | 1 | $19.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.